Effect of Green Tea Extract/Poly-gamma-Glutamic Acid Complex in Obese Type 2 Diabetic Mice.
10.4093/dmj.2013.37.3.196
- Author:
Ki Cheor BAE
1
;
Jae Hyung PARK
;
Ann Yae NA
;
Sun Joo KIM
;
Shinbyoung AHN
;
Sang Pyo KIM
;
Byung Chul OH
;
Ho Chan CHO
;
Yong Woon KIM
;
Dae Kyu SONG
Author Information
1. Department of Physiology, Keimyung University School of Medicine, Daegu, Korea. dksong@kmu.ac.kr
- Publication Type:Original Article
- Keywords:
db/db mice;
Diabetes mellitus, type 2;
Gallated catechins;
Glucose intolerance;
Obesity;
Poly-gamma-glutamic acid
- MeSH:
Absorption;
Adipose Tissue;
Animals;
Appetite;
Blood Glucose;
Catechin;
Cholesterol;
Diabetes Mellitus, Type 2;
Diet;
Eating;
Fatty Liver;
Glucose;
Glucose Intolerance;
Incidence;
Insulin Resistance;
Intestinal Absorption;
Islets of Langerhans;
Mice;
Obesity;
Polyglutamic Acid;
Prevalence;
Tea;
Weight Gain
- From:Diabetes & Metabolism Journal
2013;37(3):196-206
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: The increasing prevalence of type 2 diabetes mellitus (T2DM) is associated with the rapid spread of obesity. Obesity induces insulin resistance, resulting in beta-cell dysfunction and thus T2DM. Green tea extract (GTE) has been known to prevent obesity and T2DM, but this effect is still being debated. Our previous results suggested that circulating green tea gallated catechins (GCs) hinders postprandial blood glucose lowering, regardless of reducing glucose and cholesterol absorption when GCs are present in the intestinal lumen. This study aimed to compare the effect of GTE with that of GTE coadministered with poly-gamma-glutamic acid (gamma-PGA), which is likely to inhibit the intestinal absorption of GCs. METHODS: The db/db mice and age-matched nondiabetic mice were provided with normal chow diet containing GTE (1%), gamma-PGA (0.1%), or GTE+gamma-PGA (1%:0.1%) for 4 weeks. RESULTS: In nondiabetic mice, none of the drugs showed any effects after 4 weeks. In db/db mice, however, weight gain and body fat gain were significantly reduced in the GTE+gamma-PGA group compared to nondrug-treated db/db control mice without the corresponding changes in food intake and appetite. Glucose intolerance was also ameliorated in the GTE+gamma-PGA group. Histopathological analyses showed that GTE+gamma-PGA-treated db/db mice had a significantly reduced incidence of fatty liver and decreased pancreatic islet size. Neither GTE nor gamma-PGA treatment showed any significant results. CONCLUSION: These results suggest that GTE+gamma-PGA treatment than GTE or gamma-PGA alone may be a useful tool for preventing both obesity and obesity-induced T2DM.
